A New Treatment Option for Parkinson’s A new treatment option for Parkinson’s disease (PD) just received approval. The US Food and Drug Administration (FDA) has approved JUVMO (tavapadon) for PD ...

Parkinson’s disease (PD) progresses in stages, each presenting unique challenges and opportunities for care. When discussing Parkinson’s disease, many people reference the Hoehn and Yahr scale to ...

When most people hear the phrase “Medicare payment policy,” their eyes glaze over. It sounds technical, bureaucratic, and far removed from daily life. But for people living with Parkinson’s disease ...

Nikhil Panicker, PhD is an Assistant Professor in the Department of Neurosciences at the Cleveland Clinic. The Panicker Lab investigates the molecular mechanisms that drive pathology in Parkinson’s ...

Join us for an afternoon of relaxed, conversational discussion about Parkinson’s disease with a panel of movement disorder and rehabilitation experts. Together we’ll explore the basics of Parkinson’s, ...

This section will help you understand the basics of Parkinson’s disease, how it affects the brain, its symptoms and ongoing research.

APDA Centers for Advanced Research received $1,000,000 in funding for 2026. The Centers support large research programs which include research trainees, fellowship programs, early-stage discovery ...

APDA Care Partner Connection offers the opportunity to connect with other care partners for emotional support and sharing. The group also provides education about planning for the future and practical ...

Today we continue Parkinson’s Disease: Planning for the What-Ifs, a special series of posts to address both motor and non-motor issues of people with advanced Parkinson’s disease (PD). We are defining ...

As promised in a previous blog, I now return to the topic of the gastrointestinal (GI) tract and Parkinson’s disease (PD). As most of you know, GI symptoms are very common in PD. We will discuss what ...

Parkinson’s disease (PD) medications continue to expand, which is giving patients more options than ever before. However, choosing between different formulations, delivery systems, and add-on ...

The development of potential new medications for Parkinson’s disease (PD) medications remains very active, with multiple new medications in various stages of research development that are aiming to ...